Full Text View
Tabular View
No Study Results Posted
Related Studies
Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma
This study has been completed.
Study NCT00514085   Information provided by NCIC Clinical Trials Group

First Received on August 8, 2007.   Last Updated on July 5, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Melanoma (Skin)
Additional conditions recognized in this trial
Melanoma
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Nevi and Melanomas
Interventions listed in this trial
recombinant human interleukin-21
laboratory biomarker analysis
pharmacological study
Sponsors listed in this trial
NCIC Clinical Trials Group


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services